awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q49952154-1792461B-99B3-45A9-AFFF-69F8647100FF
Q49952154-1792461B-99B3-45A9-AFFF-69F8647100FF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q49952154-1792461B-99B3-45A9-AFFF-69F8647100FF
Phase I dose-escalation study of copanlisib in combination with gemcitabine or cisplatin plus gemcitabine in patients with advanced cancer.
P2860
Q49952154-1792461B-99B3-45A9-AFFF-69F8647100FF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q49952154-1792461B-99B3-45A9-AFFF-69F8647100FF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9c21829052a85793cd05a32936c7736ffbb3b2be
P2860
BAY 80-6946 is a highly selective intravenous PI3K inhibitor with potent p110α and p110δ activities in tumor cell lines and xenograft models.